SHERIDAN, Wyo., Oct. 8, 2026 /PRNewswire/ --

How big is the respiratory care devices market, and what is driving its growth? 

The global respiratory care devices market is valued at USD 25.5 billion in 2026 and is projected to reach USD 36.7 billion by 2031, growing at a CAGR of 7.6% over the forecast period (2026–2031), according to a new study by Wissen Research.

Behind that number is a heavy and growing disease burden. The World Health Organization estimates that COPD caused approximately 3.4 million deaths globally in 2023, while asthma affected an estimated 363 million people. With aging populations, rising sleep apnea diagnosis, and a steady shift of long-term therapy from hospitals to the home, demand is growing for ventilators, CPAP and BiPAP systems, oxygen concentrators, nebulizers, and connected monitoring devices.

Get a Free Sample of This Report to Explore Key Findings and Data:
https://www.wissenresearch.com/request-a-sample/?report=respiratory-care-devices-market

Non-Invasive, Connected, and Portable: Respiratory Care Moves Beyond the Hospital

Respiratory care is shifting from hospital-based support toward non-invasive ventilation, connected devices, and home-based respiratory care. CPAP and BiPAP systems deliver positive airway pressure without invasive airway access and are widely used in sleep apnea and selected respiratory-support applications, while high-flow nasal oxygen increasingly complements ventilatory support where clinicians want to avoid invasive ventilation. In North America, therapeutic devices, including ventilators, CPAP/BiPAP systems, oxygen therapy equipment, and nebulizers, were the largest product category in 2025.

Connectivity is the second major shift. Connected PAP devices can transmit therapy usage, adherence, and leak data to healthcare providers, allowing clinicians to identify problems and manage patients remotely. ResMed's AirSense 11 platform, which pairs cloud-based remote monitoring with over-the-air updates, illustrates the move toward connected respiratory therapy. Together with portable oxygen concentrators, home ventilators, and automated therapy adjustment, these tools let patients with chronic conditions continue treatment outside hospital walls.

The Medical Oxygen Gap: A Structural Source of Demand

Demand is shaped by access as well as disease burden. WHO notes that fewer than half of the health facilities surveyed in some low- and middle-income settings had uninterrupted access to oxygen, which supports investment in oxygen concentrators, oxygen delivery systems, ventilators, and related equipment. WHO also describes medical oxygen as a complex system that depends on reliable generation, distribution, delivery, monitoring, power supply, and trained personnel, so equipment demand is closely tied to wider healthcare-system capacity, particularly in emerging markets across Asia Pacific.

What's Fueling Growth in the Respiratory Care Devices Market

• Chronic Respiratory Disease Burden: COPD and asthma together affect more than half a billion people globally, creating sustained demand for long-term oxygen therapy, ventilation support, nebulization, and monitoring.
• Rising Sleep Apnea Diagnosis: Greater emphasis on diagnosing and managing sleep-related breathing disorders is increasing demand for CPAP and BiPAP devices.
• Aging Populations: An older population with more comorbidities is expanding the number of patients who need respiratory support.
• Shift to Home-Based Care: Portable oxygen concentrators, PAP devices, and remote therapy-management platforms are moving selected therapies out of hospitals and into homecare settings.
• Oxygen Access Gaps: Persistent shortfalls in medical oxygen availability in low- and middle-income countries are driving demand for concentrators, delivery systems, and ventilators.
• Connected, Non-Invasive Technology: Digital connectivity, automated algorithms, and non-invasive designs are improving monitoring, therapy personalization, and usability.

Challenges Facing the Respiratory Care Devices Market

Cost, reimbursement, and upkeep remain the main constraints. Respiratory equipment must be maintained, powered, cleaned, and operated by trained personnel, which raises total cost of ownership and complicates adoption in resource-constrained healthcare systems. Oxygen therapy shows the problem clearly, since effective treatment needs reliable oxygen sources, distribution, regulation, delivery, and monitoring rather than a single device.

Patient adherence is a further hurdle for long-term therapies such as CPAP and home respiratory support. Comfort, mask fit, noise, portability, and ease of use all influence whether patients keep using their devices, and healthcare providers need staff trained to select, configure, and monitor the equipment.

Recent Strategic Developments in the Respiratory Care Devices Market

In July 2026, Nihon Kohden Corporation upgraded its NKV-550 ventilator with non-invasive muscle pressure monitoring, an Adaptive Ventilation Mode, and adjustable AdaptiveSync technology, with the ventilator manufactured in the United States to strengthen its respiratory support portfolio.

In June 2026, Masimo Corporation received FDA 510(k) clearance for an AI-enabled capability on its Radius VSM wearable monitor that detects opioid-induced respiratory depression by analyzing continuous physiological data, extending connected monitoring in hospital respiratory care.

Also in June 2026, Drägerwerk AG & Co. KGaA received FDA 510(k) clearance for version 3.10 of the software on its Evita V800 ventilator, broadening the regulatory authorization for its advanced mechanical ventilation platform for critical care.

Together, these moves point to an industry investing in adaptive ventilation, AI-assisted monitoring, and continuous regulatory upgrades to its critical-care platforms.

Key Insights from Respiratory Care Devices Market Analysis

• Therapeutic respiratory care devices held the largest share by product type in 2025, covering ventilators, CPAP and BiPAP devices, oxygen therapy equipment, and nebulizers used across acute and chronic care.
• COPD held the largest share by indication in 2025, supported by long-term demand for oxygen therapy, non-invasive ventilation, nebulization, and respiratory monitoring.
• North America held the largest regional share in 2025, led by the United States, supported by high healthcare spending, established hospital and homecare networks, and a strong medical technology ecosystem.
• Asia Pacific is the fastest-growing region, driven by expanding healthcare infrastructure, rising respiratory disease burden, growing access to medical oxygen, and wider adoption of home-based respiratory care.
• The market is moderately consolidated overall but fragmented across individual product categories, with large medical technology companies competing alongside specialists in PAP therapy, humidification, and sleep apnea management.

Key Players in the Respiratory Care Devices Market

Leading companies in the respiratory care devices market are focused on non-invasive ventilation, oxygen therapy, sleep and breathing technologies, connected care, respiratory monitoring, and hospital-based respiratory support to strengthen their market positions.

Regional Analysis and Growth Opportunities

North America leads the respiratory care devices market, supported by developed healthcare infrastructure, high healthcare expenditure, and extensive use of ventilators, PAP systems, oxygen therapy equipment, nebulizers, and monitoring technologies. The United States accounts for most of the region's demand, backed by an aging population, a high burden of COPD, asthma, and sleep apnea, and an established home medical equipment sector.

Asia Pacific is the fastest-growing region, with China, Japan, India, South Korea, and Australia expanding hospital capacity, critical-care infrastructure, and home healthcare services. Growth in private hospitals, specialty respiratory centers, and sleep laboratories, along with national efforts to scale up oxygen systems, is creating new opportunities for device manufacturers.

Europe, Latin America, and the Middle East & Africa complete the report's regional coverage.

Get a Custom Briefing on This Market for Your Business

Wissen Research's healthcare technology analysts are available to walk through findings specific to your market, region, or competitive set.

Need Insights Specific to Your Business? Request a Customized Version of This Report:
https://www.wissenresearch.com/request-customization/?report=respiratory-care-devices-market

Market Segmentation Snapshot

By Product Type

• Therapeutic Respiratory Care Devices

• • Positive Airway Pressure (Pap) Devices
  • Ventilators
  • Nebulizers
  • Humidifiers
  • Oxygen Concentrators
  • Inhalers
  • Reusable Resuscitators
  • Nitric Oxide Delivery Units
  • Oxygen Hoods
• Diagnostic Respiratory Care Devices
  • Spirometers
  • Polysomnography Devices
  • Peak Flow Meters
  • Other Diagnostic Devices
• Monitoring Devices
  • Pulse Oximeters
  • Capnographs
  • Gas Analyzers
• Consumables & Accessories

By Function Type

• Asthma

• Chronic Bronchitis

• Chronic Obstructive Pulmonary Disease (COPD)

• Infectious Diseases

• Other Disease Indications (Cystic Fibrosis, Lung Cancer Etc.)

By End User Type

• Hospitals

• Diagnostic Imaging Centers

• Academic & Research Institution

• Other End Users

By Region

• North America

  • USA

  • Canada

• Europe

  • UK

  • France

  • Germany

  • Italy

  • Spain

  • Rest of Europe

• Asia-Pacific

  • China

  • India

  • Japan

  • South Korea

  • Australia and New Zealand

  • Rest of Asia Pacific

• Middle East and Africa

• Latin America

Respiratory Care Devices Market FAQs

Q: What is the size of the respiratory care devices market?
A: The global respiratory care devices market is estimated at USD 25.5 billion in 2026 and is projected to reach USD 36.7 billion by 2031.

Q: What is the growth rate of the respiratory care devices market?
A: The respiratory care devices market is projected to grow at a CAGR of 7.6% between 2026 and 2031.

Q: Which product category leads the respiratory care devices market?
A: Therapeutic respiratory care devices, including ventilators, CPAP and BiPAP devices, oxygen therapy equipment, and nebulizers, held the largest share by product type in 2025.

Q: Which indication leads the respiratory care devices market?
A: COPD held the largest share by indication in 2025, driven by long-term demand for oxygen therapy, non-invasive ventilation, nebulization, and respiratory monitoring.

Q: Which region leads the respiratory care devices market?
A: North America held the largest share of the respiratory care devices market in 2025, while Asia Pacific is the fastest-growing region through 2031.

Q: Who are the top players in the respiratory care devices market?
A: Leading companies in the respiratory care devices market include ResMed Inc., Medtronic plc, Koninklijke Philips N.V., Fisher & Paykel Healthcare, and Dräger.

Q: Why is home-based respiratory care growing?
A: Rising chronic respiratory disease, an aging population, and the availability of portable oxygen concentrators, PAP devices, and connected monitoring systems are allowing more long-term therapy to move from hospitals to the home.

As non-invasive ventilation, connected monitoring, and portable oxygen therapy continue to mature, respiratory care devices are becoming a central part of chronic disease management across hospital and home settings. For manufacturers, the path forward lies in continued investment in connectivity, patient comfort, and affordable oxygen and ventilation solutions for emerging healthcare systems.

Get the Complete Respiratory Care Devices Market Report — Forecasts, Insights & Growth Opportunities:
https://www.wissenresearch.com/market-research-reports-pricings/respiratory-care-devices-market

Expert Profile | Mayur Jain, Wissen Research 

Mayur Jain is a Research Expert at Wissen Research with multidomain expertise with more than 12+ years of experience in market research industry. 

Email: mayur@wissenresearch.com
LinkedIn:  https://www.linkedin.com/in/mayur-jain-0190542a/ 

About Wissen Research

Wissen Research is a global market intelligence and consulting firm specializing in healthcare, life sciences, technology, and emerging industries. The company provides data-driven insights, strategic market analysis, and industry forecasts to help organizations make informed business decisions and identify new growth opportunities across global markets

Company Contact:

Wissen Research LLC,
Gould St, Ste R,
Sheridan, WY 82801,
Phone: (+1) 510 240 9853
Email: info@wissenresearch.com
Website: https://www.wissenresearch.com/
Blog: https://www.wissenresearch.com/insights/
LinkedIn: https://www.linkedin.com/company/wissen-research 

View original content to download multimedia:https://www.prnewswire.com/news-releases/respiratory-care-devices-market-to-hit-us-36-7-bn-by-2031-wissen-research-302902993.html

SOURCE Wissen Research LLC